Cardiovascular Events Are Not Associated with MTHFR Polymorphisms, But Are Associated with Methotrexate Use and Traditional Risk Factors in US Veterans with Rheumatoid Arthritis

被引:26
作者
Davis, Lisa A.
Cannon, Grant W.
Pointer, Lauren F.
Haverhals, Leah M.
Wolff, Roger K.
Mikuls, Ted R.
Reimold, Andreas M.
Kerr, Gail S.
Richards, J. Steuart
Johnson, Dannette S.
Valuck, Robert
Prochazka, Allan
Caplan, Liron
机构
[1] Univ Colorado, Sch Med, Dept Rheumatol, Denver, CO USA
[2] Dept Vet Affairs, Denver, CO USA
基金
美国国家卫生研究院;
关键词
RHEUMATOID ARTHRITIS; METHOTREXATE; SINGLE-NUCLEOTIDE POLYMORPHISM; METHYLENETETRAHYDROFOLATE REDUCTASE; CARDIOVASCULAR DISEASES; METHYLENETETRAHYDROFOLATE-REDUCTASE GENE; MODIFYING ANTIRHEUMATIC DRUGS; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; SUBCLINICAL ATHEROSCLEROSIS; C677T POLYMORPHISM; UNITED-STATES; MORTALITY; VALIDATION; PREDICTORS;
D O I
10.3899/jrheum.121012
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective. C677T and A1298C polymorphisms in the enzyme methylenetetrahydrofolate reductase (MTHFR) have been associated with increased cardiovascular (CV) events in non-rheumatoid arthritis (RA) populations. We investigated potential associations of MTHFR polymorphisms and use of methotrexate (MTX) with time-to-CV event in data from the Veterans Affairs Rheumatoid Arthritis (VARA) registry. Methods. VARA participants were genotyped for MTHFR polymorphisms Variables included demographic information, baseline comorbidities, RA duration, autoantibody status, and disease activity. Patients' comorbidities and outcome variables were defined using International Classification of Diseases-9 and Current Procedural Terminology codes. The combined CV event outcome included myocardial infarction (MI), percutaneous coronary intervention, coronary artery bypass graft surgery, and stroke. Cox proportional hazards regression was used to model the time-to-CV event. Results. Data were available for 1047 subjects. Post-enrollment CV events occurred in 97 patients (9.26%). Although there was a trend toward reduced risk of CV events, MTHFR polymorphisms were not significantly associated with time-to-CV event. Time-to-CV event was associated with prior stroke (HR 2.01, 95% CI 1.03-3.90), prior MI (HR 1.70, 95% CI 1.06-2.71), hyperlipidemia (HR 1.57, 95% CI 1.01-2.43), and increased modified Charlson-Deyo index (HR 1.23, 95% CI 1.13-1.34). MTX use (HR 0.66, 95% CI 0.44-0.99) and increasing education (HR 0.87, 95% CI 0.80-0.95) were associated with a lower risk for CV events. Conclusion. Although MTHFR polymorphisms were previously associated with CV events in non-RA populations, we found only a trend toward decreased association with CV events in RA. Traditional risk factors conferred substantial CV risk, while MTX use and increasing years of education were protective.
引用
收藏
页码:809 / 817
页数:9
相关论文
共 49 条
[1]
Carotid Atherosclerosis, Disease Measures, Oxidized Low-density Lipoproteins, and Atheroprotective Natural Antibodies for Cardiovascular Disease in Early Rheumatoid Arthritis - An Inception Cohort Study [J].
Ajeganova, Sofia ;
de Faire, Ulf ;
Jogestrand, Tomas ;
Frostegard, Johan ;
Hafstroem, Ingiaeld .
JOURNAL OF RHEUMATOLOGY, 2012, 39 (06) :1146-1154
[2]
Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke [J].
Al-Allawi, Nasir A. S. ;
Avo, Arteen S. ;
Jubrael, Jaladet M. S. .
NEUROLOGY INDIA, 2009, 57 (05) :631-635
[3]
Predictors of early mortality among hospitalized nursing home residents [J].
Alrawi, Y. A. ;
Parker, R. A. ;
Harvey, R. C. ;
Sultanzadeh, S. J. ;
Patel, J. ;
Mallinson, R. ;
Potter, J. F. ;
Trepte, N. J. B. ;
Myint, P. K. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2013, 106 (01) :51-57
[4]
[Anonymous], 2006, CEREBROSPINAL FLU S1, V3, pS1
[5]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[6]
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors [J].
Birman-Deych, E ;
Waterman, AD ;
Yan, Y ;
Nilasena, DS ;
Radford, MJ ;
Gage, BF .
MEDICAL CARE, 2005, 43 (05) :480-485
[7]
Canda MT, 2012, CLIN EXP OBSTET GYN, V39, P359
[8]
Prevalence in the United States of Selected Candidate Gene Variants [J].
Chang, Man-huei ;
Lindegren, Mary Lou ;
Butler, Mary A. ;
Chanock, Stephen J. ;
Dowling, Nicole F. ;
Gallagher, Margaret ;
Moonesinghe, Ramal ;
Moore, Cynthia A. ;
Ned, Renee M. ;
Reichler, Mary R. ;
Sanders, Christopher L. ;
Welch, Robert ;
Yesupriya, Ajay ;
Khoury, Muin J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (01) :54-66
[9]
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study [J].
Choi, HK ;
Hernán, MA ;
Seeger, JD ;
Robins, JM ;
Wolfe, F .
LANCET, 2002, 359 (9313) :1173-1177
[10]
Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis:: The cardiovascular risk in young Finns study [J].
Collings, A. ;
Raitakari, O. T. ;
Juonala, M. ;
Rontu, R. ;
Kahonen, M. ;
Hutri-Kahonen, N. ;
Ronnemaa, T. ;
Marniemi, J. ;
Viikari, J. S. A. ;
Lehtimaki, T. .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (01) :22-30